{'fraction_non_alphanumeric': 0.0430327868852459, 'fraction_numerical': 0.01639344262295082, 'mean_word_length': 6.086956521739131, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Paraneoplastic movement disorder in a patient with non‐Hodgkin's lymphoma and CRMP‐5 autoantibody

The paraneoplastic autoantibody, collapsin response‐mediator protein (CRMP)‐5 immunoglobulin G (IgG), is specific for neuronal cytoplasmic CRMP‐5, and is usually associated with small‐cell lung carcinoma or thymoma. We report on details of a movement disorder that followed anti‐B‐cell therapy in a patient with lymphoma, and was accompanied by CRMP‐5 IgG. © 2003 Movement Disorder Society